Abstract:BACKGROUND: Ferroptosis is a brand-new type of controlled cell death that is distinguished by its reliance on iron and the production of lipid peroxidation. The role of ferroptosis in damaging liver disorders has attracted a lot of attention in recent years. One effective strategy to reduce liver damage is to target ferroptosis.PURPOSE: The purpose of this review is to clarify the connection between ferroptosis and liver damage and to look into the potential contribution of natural products to the clinical management of liver damage and the discovery of novel medications.METHODS: To study the methods by which natural products operate on ferroptosis to cure liver damage and their main signaling pathways, we searched databases from the time of initial publication to August 2023 in PubMed, EMBASE, Web of Science, Ovid, ScienceDirect, and China National Knowledge Infrastructure. The liver illness that each natural product treats is categorized and summarized. It's interesting to note that several natural compounds, such Artemether, Fucoidan sulfate, Curcumin, etc., have the benefit of having many targets and multiple pathways of action.RESULTS: We saw that in human samples or animal models of liver injury, ferroptosis indicators were activated, lipid peroxidation levels were elevated, and iron inhibitors had the ability to reduce liver damage. Liver damage can be treated with natural products by regulating ferroptosis. This is mostly accomplished through the modulation of Nrf2-related pathways (e.g., Conclusions and Astaxanthin), biological enzymes like GPX4 and the SIRT family (e.g., Chrysophanol and Decursin), and transcription factors like P53 (e.g., Artemether and Zeaxanthin).CONCLUSIONS: This review proposes a promising path for the therapeutic therapy of liver damage by providing a theoretical foundation for the management of ferroptosis utilizing natural ingredients.

Identifying Eleven New Ferroptosis Inhibitors As Neuroprotective Agents from FDA-approved Drugs

Inhibiting ferroptosis: A novel approach for stroke therapeutics

Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents

Design, synthesis, and biological evaluation of 2-amino-6-methyl-phenol derivatives targeting lipid peroxidation with potent anti-ferroptotic activities

Synthesis and biological evaluation of ferrostatin-based diamide derivatives as new ferroptosis inhibitors

Ferroptosis inhibitors: past, present and future

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

A new ferroptosis inhibitor, isolated from<i> Ajuga</i><i> nipponensis,</i> protects neuronal cells via activating NRF2-antioxidant response elements (AREs) pathway

Targeting ferroptosis opens new avenues for the development of novel therapeutics

Natural product-derived ferroptosis mediators

Discovery of 4-hydroxyl pyrazole derivatives as potent ferroptosis inhibitors

Synthesis and Evaluation of Smart Drugs with Integrated Functions for Identifying and Treating Oxidative Microenvironments Associated with Cellular Ferroptosis

Targeting ferroptosis: Paving new roads for drug design and discovery

Discovery and optimization of olanzapine derivatives as new ferroptosis inhibitors

Targeting Ferroptosis As a Potential Prevention and Treatmentstrategy for Human Diseases

Inhibiting Ferroptosis through Disrupting the NCOA4–FTH1 Interaction: A New Mechanism of Action

Design, Synthesis, and Biological Evaluation of New Improved Ferrostatin‐1 Derived Ferroptosis Inhibitors

Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies

Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer

Discovery and optimization of 2-(trifluoromethyl)benzimidazole derivatives as novel ferroptosis inducers <i>in vitro</i> and in <i>vivo</i>

Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases